About 900 reports
Purchase Reports From Reputable Market Research Publishers
Pancreatic Cancer: Opportunity Analysis and Forecast to 2026
- $ 10995
- Industry report
- April 2018
Pancreatic Cancer: Opportunity Analysis and Forecast to 2026SummaryPancreatic cancer is set to become the second leading cause of cancer-related deaths in the US in 2020 after lung cancer, despite accounting ...
Drug Analysis: Ofatumumab
$ 10000
November 2017
Drug OverviewOfatumumab (Genmab/Novartis) is a fully human immunoglobulin G1 and high-affinity antibody that targets a novel epitope on cluster of differentiation (CD)20 on the B-cell membrane. Ofatumuma ...